TSX Venture Exchange symbol: IBR
VANCOUVER
,
Jan. 18
/CNW/ - International Bio Recovery Corporation ("IBR") (TSX-V: IBR) is pleased to announce that it has closed a non-brokered private placement of 22,851,499 units at
$0.10
. Each unit consists of one common share and one share purchase warrant exercisable at
$0.125
for 2 years; the warrants will contain provisions that a) they cannot be exercised until four months after closing, and b) they must be exercised within 30 days of notice from IBR that the closing price of IBR's shares has been
$0.25
per share for 20 consecutive trading days.
The gross proceeds of
$2,285,149
will be used to put in place production capacity to allow commercial marketing of end products that will establish market presence and pricing and to enhance the Company's research and development capabilities.
The private placement is subject to the receipt of all necessary approvals, including approval of the TSX Venture Exchange.
The common share units have not and will not be registered under
United States
Securities Act of 1933, as amended (the U.S. Securities Act) or any state securities laws and may not be offered or sold in the
United States
except in certain transactions exempt from the registration requirements of the U.S. Securities Act and applicable states securities laws.
About IBR
Located in North
Vancouver
, BC, IBR is committed to research and development to continue to improve the efficiency of its technology and the quality of Genica branded fertility products. It is further committed to developing a world wide marketing capability to ensure market acceptance the fertility products.
THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR THE ACCURACY OF THIS RELEASE.
For further information: For further information: Ben Van Dyk, Chairman of the Board, IBR, (604) 924-1023 ext 304, (604) 924-1043 fax, [email protected]; Henry J. Bow, President & CEO, IBR, (604) 924-1023 ext 309, (604) 924-1043 fax, [email protected]
Share this article